These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 16249548)

  • 1. Development, progression, and regression of microalbuminuria in Japanese patients with type 2 diabetes under tight glycemic and blood pressure control: the Kashiwa study.
    Yamada T; Komatsu M; Komiya I; Miyahara Y; Shima Y; Matsuzaki M; Ishikawa Y; Mita R; Fujiwara M; Furusato N; Nishi K; Aizawa T
    Diabetes Care; 2005 Nov; 28(11):2733-8. PubMed ID: 16249548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Albuminuria and 24-h ambulatory blood pressure in normoalbuminuric and microalbuminuric NIDDM patients. A longitudinal study.
    Nielsen S; Schmitz A; Poulsen PL; Hansen KW; Mogensen CE
    Diabetes Care; 1995 Nov; 18(11):1434-41. PubMed ID: 8722066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of glycemic control and blood pressure in the development and progression of nephropathy in elderly Japanese NIDDM patients.
    Tanaka Y; Atsumi Y; Matsuoka K; Onuma T; Tohjima T; Kawamori R
    Diabetes Care; 1998 Jan; 21(1):116-20. PubMed ID: 9538981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of intensive glycemic control on microalbuminuria in type 2 diabetes. Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type 2 Diabetes Feasibility Trial Investigators.
    Levin SR; Coburn JW; Abraira C; Henderson WG; Colwell JA; Emanuele NV; Nuttall FQ; Sawin CT; Comstock JP; Silbert CK
    Diabetes Care; 2000 Oct; 23(10):1478-85. PubMed ID: 11023140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term lisinopril therapy reduces exercise-induced albuminuria in normoalbuminuric normotensive IDDM patients.
    Tuominen JA; Ebeling P; Koivisto VA
    Diabetes Care; 1998 Aug; 21(8):1345-8. PubMed ID: 9702445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High blood pressure is a risk factor for the development of microalbuminuria in Japanese subjects with non-insulin-dependent diabetes mellitus.
    Haneda M; Kikkawa R; Togawa M; Koya D; Kajiwara N; Uzu T; Shigeta Y
    J Diabetes Complications; 1992; 6(3):181-5. PubMed ID: 1472744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined intensive blood pressure and glycemic control does not produce an additive benefit on microvascular outcomes in type 2 diabetic patients.
    Ismail-Beigi F; Craven TE; O'Connor PJ; Karl D; Calles-Escandon J; Hramiak I; Genuth S; Cushman WC; Gerstein HC; Probstfield JL; Katz L; Schubart U;
    Kidney Int; 2012 Mar; 81(6):586-94. PubMed ID: 22166848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved pregnancy outcome in type 1 diabetic women with microalbuminuria or diabetic nephropathy: effect of intensified antihypertensive therapy?
    Nielsen LR; Damm P; Mathiesen ER
    Diabetes Care; 2009 Jan; 32(1):38-44. PubMed ID: 18945922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Canagliflozin on Urinary Albumin Excretion in Japanese Patients with Type 2 Diabetes Mellitus and Microalbuminuria: A Pilot Study.
    Osonoi T; Gouda M; Kubo M; Arakawa K; Hashimoto T; Abe M
    Diabetes Technol Ther; 2018 Oct; 20(10):681-688. PubMed ID: 30096243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Remission of diabetic nephropathy in type 2 diabetic Asian population: role of tight glucose and blood pressure control.
    Hsieh MC; Hsieh YT; Cho TJ; Chen JF; Lin SD; Chen HC; Tu ST
    Eur J Clin Invest; 2011 Aug; 41(8):870-8. PubMed ID: 21299554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between early diabetic nephropathy and control of plasma glucose in non-insulin-dependent diabetes mellitus. The effect of glycemic control on the development and progression of diabetic nephropathy in an 8-year follow-up study.
    Kawazu S; Tomono S; Shimizu M; Kato N; Ohno T; Ishii C; Murata K; Watanabe T; Negishi K; Suzuki M
    J Diabetes Complications; 1994; 8(1):13-7. PubMed ID: 8167381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic review on urine albumin testing for early detection of diabetic complications.
    Newman DJ; Mattock MB; Dawnay AB; Kerry S; McGuire A; Yaqoob M; Hitman GA; Hawke C
    Health Technol Assess; 2005 Aug; 9(30):iii-vi, xiii-163. PubMed ID: 16095545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PAIT-survey-Prevalence of albuminuria in patients with diabetes and hypertension in Turkey.
    Fici F; Bakir EA; Beyaz S; Makel W; Robles NR
    Prim Care Diabetes; 2018 Dec; 12(6):558-564. PubMed ID: 30327190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of urinary albumin excretion within the normal range in patients with type 2 diabetes: the Randomised Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) study.
    Ritz E; Viberti GC; Ruilope LM; Rabelink AJ; Izzo JL; Katayama S; Ito S; Mimran A; Menne J; Rump LC; Januszewicz A; Haller H
    Diabetologia; 2010 Jan; 53(1):49-57. PubMed ID: 19876613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Losartan reduces microalbuminuria in hypertensive microalbuminuric type 2 diabetics.
    Lozano JV; Llisterri JL; Aznar J; Redon J;
    Nephrol Dial Transplant; 2001; 16 Suppl 1():85-9. PubMed ID: 11369830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of empagliflozin on the urinary albumin-to-creatinine ratio in patients with type 2 diabetes and established cardiovascular disease: an exploratory analysis from the EMPA-REG OUTCOME randomised, placebo-controlled trial.
    Cherney DZI; Zinman B; Inzucchi SE; Koitka-Weber A; Mattheus M; von Eynatten M; Wanner C
    Lancet Diabetes Endocrinol; 2017 Aug; 5(8):610-621. PubMed ID: 28666775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fenofibrate reduces progression to microalbuminuria over 3 years in a placebo-controlled study in type 2 diabetes: results from the Diabetes Atherosclerosis Intervention Study (DAIS).
    Ansquer JC; Foucher C; Rattier S; Taskinen MR; Steiner G;
    Am J Kidney Dis; 2005 Mar; 45(3):485-93. PubMed ID: 15754270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of metabolic and blood pressure control on incidence and progression of nephropathy. A 10-year study of 385 type 2 diabetic patients.
    Torffvit O; Agardh CD
    J Diabetes Complications; 2001; 15(6):307-13. PubMed ID: 11711324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rate of progression of albuminuria in type II diabetes. Five-year prospective study from south India.
    John L; Rao PS; Kanagasabapathy AS
    Diabetes Care; 1994 Aug; 17(8):888-90. PubMed ID: 7956637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Albuminuria and poor glycemic control predict mortality in NIDDM.
    Gall MA; Borch-Johnsen K; Hougaard P; Nielsen FS; Parving HH
    Diabetes; 1995 Nov; 44(11):1303-9. PubMed ID: 7589828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.